5-Chloro-1H-indole-2,3-dione has been researched along with 5-bromoisatin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chibale, K; Chiyanzu, I; Gut, J; Hansell, E; McKerrow, JH; Rosenthal, PJ | 1 |
Danks, MK; Edwards, CC; Hatfield, MJ; Hyatt, JL; Moak, T; Potter, PM; Tsurkan, L; Wadkins, RM; Wierdl, M | 1 |
Boardman, P; Choi, K; Griffin, JH; Jin, X; Khosla, C; Klöck, C; Lanza, G; Madrid, PB; Raimundo, BC; Spencer, A | 1 |
Dung, do TM; Dung, PT; Han, BW; Han, SB; Huong, TL; Kang, JS; Kim, KR; Kim, Y; Nam, NH; Oanh, DT; Park, SH; Quyen, D; Thao, le T; Yun, J | 1 |
Chen, J; Chen, WQ; Liu, W; Niu, GJ; Shi, EZ; Sun, B; Yang, C; Zhou, HG; Zhu, HM | 1 |
Guo, Q; Han, K; Liu, F; Liu, W; Song, B; Teng, Y; Wang, P; Yang, Y; Yao, Q; Yu, P; Zhou, Y | 1 |
Fan, ZC; Gao, ML; Han, KL; Liu, H; Sun, H; Teng, YO; Wang, J; Yu, P; Zhang, YM; Zhao, HY; Zhou, Y | 1 |
7 other study(ies) available for 5-Chloro-1H-indole-2,3-dione and 5-bromoisatin
Article | Year |
---|---|
Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain.
Topics: Drug Evaluation, Preclinical; Isatin; Magnetic Resonance Spectroscopy; Protease Inhibitors; Spectrometry, Mass, Fast Atom Bombardment; Thiosemicarbazones | 2003 |
Selective inhibition of carboxylesterases by isatins, indole-2,3-diones.
Topics: Acetylcholinesterase; Butyrylcholinesterase; Carboxylic Ester Hydrolases; Cholinesterase Inhibitors; Humans; Hydrophobic and Hydrophilic Interactions; Isatin; Models, Molecular; Quantitative Structure-Activity Relationship | 2007 |
Acylideneoxoindoles: a new class of reversible inhibitors of human transglutaminase 2.
Topics: Enzyme Activation; Enzyme Inhibitors; GTP-Binding Proteins; Humans; Indoles; Inhibitory Concentration 50; Protein Glutamine gamma Glutamyltransferase 2; Structure-Activity Relationship; Transglutaminases | 2011 |
Novel isatin-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Hydroxamic Acids; Isatin; Molecular Structure; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Structure-Activity Relationship | 2013 |
Synthesis, modification and docking studies of 5-sulfonyl isatin derivatives as SARS-CoV 3C-like protease inhibitors.
Topics: Humans; Isatin; Molecular Structure; Protease Inhibitors; Severe acute respiratory syndrome-related coronavirus; Structure-Activity Relationship | 2014 |
Design, synthesis and in vitro cytotoxicity evaluation of 5-(2-carboxyethenyl)isatin derivatives as anticancer agents.
Topics: Antineoplastic Agents; Apoptosis; Cytotoxins; Drug Design; Drug Screening Assays, Antitumor; Hep G2 Cells; HT29 Cells; Humans; K562 Cells | 2014 |
Synthesis and anti-cancer activity evaluation of 5-(2-carboxyethenyl)-isatin derivatives.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Isatin; Jurkat Cells; Leukemia, T-Cell; Membrane Potential, Mitochondrial; Mitochondria; Neoplasms | 2016 |